About The Position

The Director, Pricing and Market Access Strategy Lead (PASL) for Immunology will lead the Global Market Access strategy for admilparant across international markets. Admilparant is a potential first-in-class oral LPA1 antagonist in development for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Following positive Phase 3 ALOFT-IPF results, the asset is moving toward regulatory submissions, with topline results from the fully enrolled ALOFT-PPF trial expected in early 2027. The role will shape the asset’s access strategy, evidence generation, and key development and commercialization decisions as it moves toward potential launch. Reporting to the Executive Director, GMAx Global Launch Strategy for Cardiovascular and Immunology, the Director will serve as the Market Access representative on the Global Product Team. The role partners across Commercial, Medical, Regulatory, Clinical, Advocacy, Policy, Business Insights and Analytics, HEOR, and markets worldwide, and contributes to market access and pricing governance. The successful candidate will bring deep global pricing and market access expertise, sound strategic judgment, and the ability to influence senior leaders and collaborate inclusively across functions and geographies.

Requirements

  • Undergraduate degree.
  • Significant experience in global market access, pricing, reimbursement, and/or HEOR within the pharmaceutical or biotechnology industry; ideally includes responsibility for global strategy.
  • Strong knowledge of the global access environment and ability to translate payer, HTA, pricing, reimbursement, and policy developments into product-strategy implications.
  • Experience shaping access strategy for assets in development or preparing for launch.
  • Strong understanding of pharmaceutical development and commercialization, including assessment of clinical trial designs, endpoints, and evidence plans from a payer and HTA perspective.
  • Experience developing payer value propositions and evidence strategies integrating clinical, humanistic, and economic value.
  • Strong strategic judgment, business and financial acumen, and ability to synthesize complex evidence and differing perspectives into clear recommendations.
  • Ability to communicate complex access issues clearly and credibly to senior leaders and cross-functional stakeholders, including audiences without deep Market Access expertise.
  • Demonstrated ability to lead through influence in a global matrix, build alignment across functions and markets, and constructively challenge assumptions.
  • Ability to prioritize and deliver multiple complex projects in a fast-moving environment, including amid ambiguity or incomplete information.
  • Inclusive and collaborative leadership style, with cultural awareness to work effectively across countries, functions, and perspectives.
  • Ability to travel internationally as required.
  • Consistent demonstration of BMS Behaviors: Integrity, Inclusion, Accountability, Innovation, Passion, and Speed.

Nice To Haves

  • MBA, MPH, MSc, PhD, or other relevant advanced degree (preferred but not required).
  • Experience in immunology, respiratory disease, pulmonary fibrosis, or another specialty area.

Responsibilities

  • Lead the integrated Global Market Access strategy for admilparant in partnership with HEOR, developing differentiated payer value propositions across clinical, humanistic, and economic dimensions.
  • Shape the evidence-generation strategy, ensuring interventional, non-interventional, and real-world evidence addresses payer, HTA body, and other access decision-maker needs.
  • Represent Market Access on the Global Product Team and influence development and commercialization decisions, including clinical trial designs, endpoints, and evidence plans that support future access and reimbursement.
  • Partner with HEOR and Regulatory to identify opportunities for an optimal product label and relevant patient-reported outcome claims that strengthen the payer value proposition and long-term asset value.
  • Translate pricing, reimbursement, policy, and competitive developments into strategic implications, partnering with Business Insights and Analytics, markets, and other stakeholders to anticipate access-environment changes.
  • Embed access and pricing considerations into global brand and commercialization strategy, reflecting payer and HTA requirements across key geographies.
  • Lead the Global Market Access Core Value Team for admilparant, aligning functions and markets on strategy, priorities, and execution.
  • Drive critical Market Access projects and milestones, coordinating cross-functional partners, resolving dependencies, and keeping decisions and deliverables focused on launch readiness and access success.
  • Contribute to Market Access and pricing governance by presenting clear recommendations and helping senior stakeholders navigate strategic trade-offs.
  • Travel internationally for congresses, market engagements, and internal meetings as required.

Benefits

  • Comprehensive benefit plans, including wellbeing support, retirement and financial protection benefits, and medical, dental, vision, life, and disability insurance offerings.
  • Flexible Time Off (FTO) for eligible U.S.-based exempt employees, subject to manager approval.
  • Paid company holidays: 11 annually.
  • For eligible non-exempt employees, RayzeBio employees, and employees located in Puerto Rico: 160 hours of paid vacation annually for new hires, subject to manager approval, plus 3 optional holidays.
  • Depending on eligibility, paid sick leave, up to two paid volunteer days per year, summer-hours flexibility, and leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs.
  • Annual Global Shutdown between Christmas Day and New Year's Day for eligible employees.
  • Potential eligibility for discretionary incentive cash and stock opportunities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service